Conservative management of abnormally invasive placentation

Obstetrical and Gynecological Survey

Volumn 62, Issue 8, 2007, Pages 529-539

  Timmermans, Sarah ^a   Van Hof, Arjanneke C ^b   Duvekot, Johannes J ^c  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b IKAZIA HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE;

ARTERY LIGATION; ARTIFICIAL EMBOLISM; CESAREAN SECTION; CONSERVATIVE TREATMENT; DISSEMINATED INTRAVASCULAR CLOTTING; EMBASE; FEMALE; FETUS MONITORING; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; INFECTION; MEDLINE; PLACENTA ACCRETA; PLACENTA DISORDER; PLACENTA PREVIA; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE ARTERY; UTERINE ARTERY EMBOLIZATION; VAGINA BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; CESAREAN SECTION; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYSTERECTOMY; METHOTREXATE; PLACENTA; PLACENTA ACCRETA; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 34547622441     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000271133.27011.05     Document Type: Review

References (71)

1. Irving FC, Hertig AT. A study of placenta accreta. Surg Gynaecol Obstet 1937;64:178-200.
2. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-1461.
3. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997;177:210-214.
4. Hung TH, Shau WY, Hsieh CC, et al. Risk factors for placenta accreta. Obstet Gynecol 1999;93:545-550.
5. Lam H, Pun TC, Lam PW. Successful conservative management of placenta previa accreta during cesarean section. Int J Gynaecol Obstet 2004;86:31-32.
6. Placenta accreta. ACOG Committee Opinion. No. 266. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:169-170.
7. O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996;175:1632-1638.
8. Kayem G, Davy C, Goffinet F, et al. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol 2004;104:531-536.
9. Kwee A, Bots ML, Visser GH, et al. Emergency peripartum hysterectomy: a prospective study in The Netherlands. Eur J Obstet Gynecol Reprod Biol 2006;124:187-192.
10. Wang PH, Chao HT, Yuan CC, et al. Placenta previa accreta with cervical involvement causing tenacious postpartum hemorrhage: a case report. Zhonghua Yi Xue Za Zhi 1998;61:116-120.
11. Veenstra MJ, Spinder T, Dekker GA, et al. Post partum intraabdominal hemorrhage due to placenta percreta. Eur J Obstet Gynecol Reprod Biol 1995;62:253-256.
12. Mechery J, Burch D. Alternative management of placenta accreta. Gynecol Surg 2006;3:41-42.
13. Kulkarni A, Draycott T. The use of serial betaHCG to plan surgical evacuation of retained placenta in a case of placenta accreta. J Matern Fetal Neonatal Med 2005;17:295-297.
14. Komulainen MH, Vayrynen MA, Kauko ML, et al. Two cases of placenta accreta managed conservatively. Eur J Obstet Gynecol Reprod Biol 1995;62:135-137.
15. Taylor AA, Sanusi FA, Riddle AF. Expectant management of placenta accreta following stillbirth at term: a case report. Eur J Obstet Gynecol Reprod Biol 2000;96:220-222.
16. Panoskaltsis TA, Ascarelli A, de Souza N, et al. Placenta increta: evaluation of radiological investigations and therapeutic options of conservative management. BJOG 2000;107:802-806.
17. Otsubo Y, Shinagawa T, Chihara H, et al. Conservative management of a case of placenta praevia percreta. Aust N Z J Obstet Gynaecol 1999;39:518-519.
18. Sinha P, Oniya O, Bewley S. Coping with placenta praevia and accreta in a DGH setting and words of caution. J Obstet Gynaecol 2005;25:334-337.
19. Downes E, Rushman N, Tyack A. The role of outpatient hysteroscopy in the conservative management of placenta accreta. Gynaecol Endosc 1995;4:147-148.
20. Lee LC, Lin HH, Wang CW, et al. Successful conservative management of placenta percreta with rectal involvement in a primigravida. Acta Obstet Gynecol Scand 1995;74:839-841.
21. Morken NH, Kahn JA. Placenta accreta and methotrexate treatment. Acta Obstet Gynecol Scand 2006;85:248-250.
22. Wong HS, Parker S. Ultrasonographic findings in conservatively treated placenta percreta. Ultrasound Obstet Gynecol 2005;26:580-581.
23. Chauveaud-Lambling A, Antonetti-N'Diaye E, de Rudnicki S, et al. Management of placenta percreta. J Gynecol Obstet Biol Reprod 2005;34:346-350.
24. Luo G, Perni SC, Jean-Pierre C, et al. Failure of conservative management of placenta previa-percreta. J Perinat Med 2005;33:564-568.
25. Butt K, Gagnon A, Delisle MF. Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet Gynecol 2002;99:981-982.
26. Mussalli GM, Shah J, Berck DJ, et al. Placenta accreta and methotrexate therapy: three case reports. J Perinatol 2000;20:331-334.
27. Jaffe R, DuBeshter B, Sherer DM, et al. Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol 1994;171:558-559.
28. Valayatham V, Rao S, Nath R, et al. A case of placenta percreta with bladder involvement managed conservatively. J Obstet Gynaecol 2005;25:397-398.
29. Gupta D, Sinha R. Management of placenta accreta with oral methotrexate. Int J Gynaecol Obstet 1998;60:171-173.
30. Ghani R. Conservative management of placenta accreta. J Obstet Gynaecol 2001;21:535.
31. Buckshee K, Dadhwal V. Medical management of placenta accreta. Int J Gynaecol Obstet 1997;59:47-48.
32. Raziel A, Golan A, Ariely S, et al. Repeated ultrasonography and intramuscular methotrexate in the conservative management of residual adherent placenta. J Clin Ultrasound 1992;20:288-290.
33. Arulkumaran S, Ng CS, Ingemarsson I, et al. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand 1986;65:285-286.
34. Henrich W, Fuchs I, Ehrenstein T, et al. Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in a woman infected with HIV. Ultrasound Obstet Gynecol 2002;20:90-93.
35. Crespo R, Lapresta M, Madani B. Conservative treatment of placenta increta with methotrexate. Int J Gynaecol Obstet 2005;91:162-163.
36. Cole MD. Using methotrexate to treat placenta accreta. AWHONN Lifelines 2002;6:486-487.
37. Legro RS, Price FV, Hill LM, et al. Nonsurgical management of placenta percreta: a case report. Obstet Gynecol 1994;83:847-849.
38. Clement D, Kayem G, Cabrol D. Conservative treatment of placenta percreta: a safe alternative. Eur J Obstet Gynecol Reprod Biol 2004;114:108-109.
39. Fiori O, Berkane N, Uzan S. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol 2005;105:219-220.
40. Dinkel HP, Durig P, Schnatterbeck P, et al. Percutaneous treatment of placenta percreta using coil embolization. J Endovasc Ther 2003;10:158-162.
41. Silver LE, Hobel CJ, Lagasse L, et al. Placenta praevia percreta with bladder involvement: new considerations and review of the literature. Ultrasound Obstet Gynecol 1997;9:131-138.
42. Lemercier E, Genevois A, Descargue G, et al. MRI evaluation of placenta accreta treated by embolization. Apropos of a case. Review of the literature. J Radiol 1999;80:383-387.
43. Bennett MJ, Sen RC. 'Conservative' management of placenta praevia percreta: report of two cases and discussion of current management options. Aust N Z J Obstet Gynaecol 2003;43:249-251.
44. Descargues G, Clavier E, Lemercier E, et al. Placenta percreta with bladder invasion managed by arterial embolization and manual removal after cesarean. Obstet Gynecol 2000;96:840.
45. Weinstein A, Chandra P, Schiavello H, et al. Conservative management of placenta previa percreta in a Jehovah's Witness. Obstet Gynecol 2005;105:1247-1250.
46. Kayem G, Pannier E, Goffinet F, et al. Fertility after conservative treatment of placenta accreta. Fertil Steril 2002;78:637-638.
47. Courbiere B, Bretelle F, Porcu G, et al. Conservative treatment of placenta accreta. J Gynecol Obstet Biol Reprod 2003;32:549-554.
48. Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985;66:89-92.
49. McKeogh RP, D'Errico E. Placenta accreta: clinical manifestations and conservative management. N Engl J Med 1951;245:159-165.
50. Millar WG. A clinical and pathological study of placenta accreta. J Obstet Gynaecol Br Emp 1959;66:353-364.
51. Fox H. Placenta accreta, 1945-1969. Obstet Gynecol Surv 1972;27:475.
52. Read JA, Cotton DB, Miller FC. Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 1980;56:31-34.
53. Chou MM, Hwang JI, Tseng JJ, et al. Internal iliac artery embolization before hysterectomy for placenta accreta. J Vasc Interv Radiol 2003;14:1195-1199.
54. Winick M, Coscia A, Noble A. Cellular growth in human placenta. I. Normal placental growth. Pediatrics 1967;39:248-251.
55. Matsumura N, Inoue T, Fukuoka M, et al. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. J Obstet Gynaecol Res 2000;26:81-87.
56. Pelage JP, Le Dref O, Jacob D, et al. Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand 1999;78:698-703.
57. Bodner LJ, Nosher JL, Gribbin C, et al. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol 2006;29:354-361.
58. Chou YJ, Cheng YF, Shen CC, et al. Failure of uterine arterial embolization: placenta accreta with profuse postpartum hemorrhage. Acta Obstet Gynecol Scand 2004;83:688-690.
59. Alkazaleh F, Geary M, Kingdom J, et al. Elective nonremoval of the placenta and prophylactic uterine artery embolization postpartum as a diagnostic imaging approach for the management of placenta percreta: a case report. J Obstet Gynaecol Can 2004;26:743-746.
60. Hollander DI, Pupkin MJ, Crenshaw MC, et al. Conservative management of placenta accreta. A case report. J Reprod Med 1988;33:74-78.
61. Korhonen J, Alfthan H, Ylostalo P, et al. Disappearance of human chorionic gonadotropin and its alpha- and beta-subunits after term pregnancy. Clin Chem 1997;43:2155-2163.
62. Adair SR, Elamin D, Tharmaratnam S. Placenta increta; conservative management: a successful outcome. Case report and literature review. J Matern Fetal Neonatal Med 2004;15:275-278.
63. Chou MM, Ho ES, Lee YH, et al. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000;15:28-35.
64. Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol 2005;26:89-96.
65. Comstock CH, Love JJ Jr, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004;190:1135-1140.
66. Chou MM, Tseng JJ, Ho ES. Usefulness of gray-scale ultrasound and complementary color Doppler ultrasound in the prenatal diagnosis of placenta previa accreta. Am J Obstet Gynecol 2005;192:1349.
67. Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 2005;84:716-724.
68. Morken NH, Henriksen H. Placenta percreta - two cases and review of the literature. Eur J Obstet Gynecol Reprod Biol 2001;100:112-115.
69. Scarantino SE, Reilly JG, Moretti ML, et al. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol 1999;94:825-827.
70. Gibb DM, Soothill PW, Ward KJ. Conservative management of placenta accreta. Br J Obstet Gynaecol 1994;101:79-80.
71. Dunstone SJ, Leibowitz CB. Conservative management of placenta praevia with a high risk of placenta accreta. Aust N Z J Obstet Gynaecol 1998;38:429-433.